Brief: RepliCel Life Sciences says patent granted for injection device technologies
Jan 11 (Reuters) - RepliCel Life Sciences Inc RP.V : * Says it has been granted a patent by the European patent office for its injection device technologies * Source text for Eikon urn:newsml:reuters.com:*:nCCN9cKv75 * Further company coverage RP.V ((Bengaluru Newsroom; +1 646 223 8780))
Recent news on Replicel Life Sciences
See all newsBrief: Replicel Life Sciences Announces Reinstatement Of Trading & Conditional Acceptance For Proposed Transaction
Brief: Replicel Life Sciences Says Replicel Announces A Letter Of Intent For Asset Purchase Agreement
Brief: Replicel Announces Binding Term Sheet For Strategic Investment And U.S. Partnership
Brief: Replicel Announces Its Incoming Board Of Directors
Brief: RepliCel Life Sciences Retains Dermatology Sales And Marketing Executive To Guide Global Commercial Strategy For Automated Dermal Injector